首頁
瀏覽量: 174
- 產品名稱： Research Grade Erenumab ( 厄瑞努單抗 )
- 產品貨號： CSD00440
- 貨期： 現(xiàn)貨
- 價格與訂購： 2480
- 數量：
庫存： 100
- 規(guī)格： 100μg
- 產品信息
- 如何訂購
貨號（Catalog No.）
CSD00440
通用名INN
Erenumab
純度(Purity)
>95%
濃度( Concentration)
1mg/ml
Formulation
PBS buffer PH7.5
Source
CHO cells
內毒素(Endotoxin level)
Please contact with the lab for this information.
產品描述(Description)
Erenumab (AMG-334) (INN; trade name Aimovig) is a human monoclonal antibody designed specifically to bind and antagonize the calcitonin gene-related peptide receptor (CGRPR) as a means to prevent migraines. Aimovig, as released and marketed by Novartis and Amgen, is in fact a novel therapeutic approach as the first and only FDA approved treatment specifically developed to prevent migraine by blocking the CGRP receptor, which is believed to play a critical role in migraine .
別名(Alternative names)
AMG 334,erenumab-aooe
靶點;物種(Specificity target name;species)
CALCRL/CGRP-R[Homo sapiens]
種類(Species)
Homo sapiens
受體鑒定(Receptor identification)
IgG2-lambda
分子量(MV)
150000.00 Da
CAS
1582205-90-0
存儲條件(Storage)
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Store at +4°C short term (1-2 weeks).
Store at -20 °C 12 months.
Store at -80°C long term.
Note
For research use only .
地 址：
產品銷售：
E - mail ：
郵 編：
Amily
